Gardiner Paula, Adams Denise, Filippelli Amanda C, Nasser Hafsa, Saper Robert, White Laura, Vohra Sunita
Department of Family Medicine, Boston Medical Center, Massachusetts, United States.
CARE Program, Department of Pediatrics, University of Alberta, Edmonton, Canada.
Glob Adv Health Med. 2013 Mar;2(2):46-55. doi: 10.7453/gahmj.2012.071.
Information about the safety of herbal medicine often comes from case reports published in the medical literature, thus necessitating good quality reporting of these adverse events. The purpose of this study was to perform a systematic review of the comprehensiveness of reporting of published case reports of adverse events associated with herb use in the pediatric population.
Electronic literature search included 7 databases and a manual search of retrieved articles from inception through 2010. We included published case reports and case series that reported an adverse event associated with exposure to an herbal product by children under the age of 18 years old. We used descriptive statistics. Based on the International Society of Epidemiology's "Guidelines for Submitting Adverse Events Reports for Publication," we developed and assigned a guideline adherence score (0-17) to each case report.
Ninety-six unique journal papers were identified and represented 128 cases. Of the 128 cases, 37% occurred in children under 2 years old, 38% between the ages of 2 and 8 years old, and 23% between the ages of 9 and 18 years old. Twenty-nine percent of cases were the result of an intentional ingestion while 36% were from an unintentional ingestion. Fifty-two percent of cases documented the Latin binomial of the herb ingredients; 41% documented plant part. Thirty-two percent of the cases reported laboratory testing of the herb, 20% documented the manufacturer of the product, and 22% percent included an assessment of the potential concomitant therapies that could have been influential in the adverse events. Mean guideline adherence score was 12.5 (range 6-17).
There is considerable need for improvement in reporting adverse events in children following herb use. Without better quality reporting, adverse event reports cannot be interpreted reliably and do not contribute in a meaningful way to guiding recommendations for medicinal herb use.
草药安全性信息通常来源于医学文献中发表的病例报告,因此需要对这些不良事件进行高质量报告。本研究的目的是对已发表的儿科人群草药使用相关不良事件病例报告的报告完整性进行系统评价。
电子文献检索包括7个数据库,并对从创刊至2010年检索到的文章进行手工检索。我们纳入了已发表的病例报告和病例系列,这些报告报道了18岁以下儿童接触草药产品相关的不良事件。我们采用描述性统计方法。根据国际流行病学协会的“提交不良事件报告以供发表的指南”,我们为每个病例报告制定并分配了一个指南依从性评分(0 - 17分)。
共识别出96篇独特的期刊论文,代表128例病例。在这128例病例中,37%发生在2岁以下儿童,38%发生在2至8岁之间,23%发生在9至满18岁之间。29%的病例是故意摄入所致,36%是无意摄入所致。52%的病例记录了草药成分的拉丁双名法;41%记录了植物部位。32%的病例报告了草药的实验室检测,20%记录了产品制造商,22%纳入了对可能对不良事件有影响的潜在伴随治疗的评估。平均指南依从性评分为12.5(范围6 - 17)。
在报告儿童草药使用后的不良事件方面,有相当大的改进需求。如果没有更高质量的报告,不良事件报告就无法得到可靠解读,也无法以有意义的方式为指导草药使用建议做出贡献。